Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -6.870% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCC1(c2ccc(F)cc2)NC(=O)N(CC(=O)Nc2ccc(S(N)(=O)=O)cc2)C1=O
b) Cc1nn(C)c(C)c1CN(Cc1nc(-c2ccc(F)cc2F)oc1C)C1CC1
Answer: b. Cc1nn(C)c(C)c1CN(Cc1nc(-c2ccc(F)cc2F)oc1C)C1CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(C)c(C)c1CN(Cc1nc(-c2ccc(F)cc2F)oc1C)C1CC1
Cc1nn(C)c(C)c1CN(Cc1nc(-c2ccc(F)cc2F)oc1C)C1CC1
N-[[2-(2,4-difluorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl]-N-[(1,3,5-trimethylpyrazol-4-yl)methyl]cyclopropanamine